PCA
IRWD icon

Private Capital Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Private Capital Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-133,728
Closed -$1.3M – 106
2013
Q4 		$1.3M Sell
133,728
-143,877
-52% -$1.29M 0.45% 62
2013
Q3 		$2.75M Hold
277,605
– – 1% 46
2013
Q2 		$2.31M Buy
+277,605
New +$3.36M 0.86% 50

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Private Capital Advisors's IRWD Position: Q1 2014 in Review

Private Capital Advisors sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2014, closing a stake of 133,728 shares — an estimated $1.3M sold.

Private Capital Advisors first reported a position in IRWD in Q2 2013 and held it in 3 quarters. The position peaked at $2.75M in Q3 2013. 138 funds tracked by Wall St. Rank hold IRWD as of Q1 2014.

  • Private Capital Advisors reported no remaining Ironwood Pharmaceuticals position as of Q1 2014 after selling out during the quarter.
  • Private Capital Advisors sold 133,728 Ironwood Pharmaceuticals shares in Q1 2014, an estimated $1.3M.
  • Private Capital Advisors first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 3 quarters.
  • Private Capital Advisors's Ironwood Pharmaceuticals position peaked at $2.75M in Q3 2013.
  • 138 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2014.

Based on Private Capital Advisors's 13F filing for Q1 2014, filed 23 Apr 2014.